Also trades as: TDSGF (OTC) · $vol 0M
TELO.V TSXV
Telo Genomics Corp.
1W: +71.4%
1M: +50.0%
3M: +33.3%
YTD: +50.0%
1Y: -25.0%
3Y: -78.6%
5Y: -87.1%
C$0.06 ($0.04)
+0.01 (+10.00%)
Weekly Expected Move ±26.5%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$2M
+5.3% ▲
Capital Expenditures
$3K
+36.5% ▲
5Y CAGR: -17.8%
Free Cash Flow
-$2M
+5.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$7K
+99.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$2M | -$3M | -$3M | -$3M |
| Depreciation & Amort. | $62K | $57K | $33K | $40K | $14K |
| Stock-Based Comp. | $142K | $151K | $160K | $0 | $268K |
| Change in Working Capital | -$51K | $107K | -$2K | $158K | $41K |
| Other Non-Cash Items | -$183K | $207K | $252K | $56K | $67K |
| Operating Cash Flow | -$1M | -$2M | -$3M | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9K | -$25K | -$69K | -$5K | -$3K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$9K | -$25K | -$69K | -$5K | -$3K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | -$8K | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $682K | -$147K | -$63K | -$221K |
| Financing Cash Flow | $4M | $877K | $3M | $587K | $2M |
| Net Change in Cash | $3M | -$944K | -$20K | -$2M | -$7K |
| Cash End of Period | $4M | $3M | $3M | $796K | $789K |
| Free Cash Flow | -$1M | -$2M | -$3M | -$2M | -$2M |